1. Home
  2. Labeler Index
  3. Merck Sharp & Dohme Llc
  4. 0085-4331
  5. Product Images: Noxafil

Product Images Noxafil

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. Figure 1 - noxafil 01
  2. Chemical Structure - noxafil 02
  3. Figure A - noxafil 02a
  4. PRINCIPAL DISPLAY PANEL - 105 mL Bottle Carton - noxafil 03
  5. Principal Display Panel - 60 Tablet Bottle Label - noxafil 04
  6. Principal Display Panel - 16.7 mL Vial Carton - noxafil 05
  7. Figure - noxafil 06
  8. Figure - noxafil 07
  9. Figure - noxafil 08
  10. Figure - noxafil 09
  11. Figure - noxafil 10
  12. Figure - noxafil 11
  13. Figure - noxafil 12
  14. Figure - noxafil 13
  15. Figure - noxafil 14
  16. Figure - noxafil 15
  17. Figure - noxafil 16
  18. Figure - noxafil 17
  19. Figure - noxafil 18
  20. Figure - noxafil 19
  21. Figure - noxafil 20
  22. Figure - noxafil 21
  23. Figure - noxafil 22
  24. Figure - noxafil 23
  25. Figure - noxafil 24
  26. Figure - noxafil 25
  27. Figure - noxafil 26
  28. Figure - noxafil 27
  29. Figure - noxafil 28
  30. Figure - noxafil 29
  31. Figure - noxafil 30
  32. Figure - noxafil 31
  33. Figure - noxafil 32
  34. Figure - noxafil 33
  35. Figure - noxafil 34
  36. Figure - noxafil 35
  37. Figure - noxafil 36
  38. Figure - noxafil 37
  39. Figure - noxafil 38
  40. Figure - noxafil 39
  41. Figure - noxafil 40
  42. Figure - noxafil 41
  43. Figure - noxafil 42
  44. Principal Display Panel - 300 mg Carton - noxafil 43

Product Label Images

The following 44 images provide visual information about the product associated with Noxafil NDC 0085-4331 by Merck Sharp & Dohme Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - noxafil 01

Figure 1 - noxafil 01

Chemical Structure - noxafil 02

Chemical Structure - noxafil 02

Figure A - noxafil 02a

Figure A - noxafil 02a

PRINCIPAL DISPLAY PANEL - 105 mL Bottle Carton - noxafil 03

PRINCIPAL DISPLAY PANEL - 105 mL Bottle Carton - noxafil 03

NOXAFIL is an oral suspension medication that comes in a package of 105 mL. Each 5 mL contains 200mg of posaconazole. The medication comes with a measuring spoon for an accurate dosage. It is essential to note that NOXAFIL oral suspension and delayed-release tablets cannot be interchanged due to the difference in dosing. It is recommended to store the medication at 77°F and to shake the medication before consuming it.*

Principal Display Panel - 60 Tablet Bottle Label - noxafil 04

Principal Display Panel - 60 Tablet Bottle Label - noxafil 04

Noxafl is a prescription medication that comes in a delayed-release tablet form containing 100mg of posaconazole. The medication is not interchangeable with Noxafl Oral Suspension due to differences in dosing. The tablets should be stored at room temperature between 68-77°F and 59-86°F. The product has a National Drug Code (NDC) of 0085-4324-02 and a GTIN of 00300854324025. The package contains 60 tablets.*

Principal Display Panel - 16.7 mL Vial Carton - noxafil 05

Principal Display Panel - 16.7 mL Vial Carton - noxafil 05

Noxafil is an injectable medication containing 300mg posaconazole per 16.7 mL via, intended for intravenous use only. Inactive ingredients include 668 betadex suffobutyl ether sodium, 00033g edetate disodium, and hycochloric acid and sodium hydroxide to adjust the pH. The medication is manufactured for Merck Sharp & Dohme Corp, a subsidiary of Merck & Co, Inc. and manufactured by MSD International GmbH in Ireland. Noxafil is a clear, sterile solution that requires further dilution prior to infusion. The usual dosage information can be found in the accompanying directions, and any remaining solution should be stored in the refrigerator for up to 24 hours. The product is a sterile single-dose vial and requires a prescription.*

Figure - noxafil 06

Figure - noxafil 06

Figure - noxafil 07

Figure - noxafil 07

Figure - noxafil 08

Figure - noxafil 08

Figure - noxafil 09

Figure - noxafil 09

Figure - noxafil 10

Figure - noxafil 10

Figure - noxafil 11

Figure - noxafil 11

Figure - noxafil 12

Figure - noxafil 12

Figure - noxafil 13

Figure - noxafil 13

Figure - noxafil 14

Figure - noxafil 14

Figure - noxafil 15

Figure - noxafil 15

Figure - noxafil 16

Figure - noxafil 16

Figure - noxafil 17

Figure - noxafil 17

Figure - noxafil 18

Figure - noxafil 18

Figure - noxafil 19

Figure - noxafil 19

Figure - noxafil 20

Figure - noxafil 20

Figure - noxafil 21

Figure - noxafil 21

Figure - noxafil 22

Figure - noxafil 22

Figure - noxafil 23

Figure - noxafil 23

Figure - noxafil 24

Figure - noxafil 24

Figure - noxafil 25

Figure - noxafil 25

Figure - noxafil 26

Figure - noxafil 26

Figure - noxafil 27

Figure - noxafil 27

Figure - noxafil 28

Figure - noxafil 28

Figure - noxafil 29

Figure - noxafil 29

Figure - noxafil 30

Figure - noxafil 30

Figure - noxafil 31

Figure - noxafil 31

Figure - noxafil 32

Figure - noxafil 32

Figure - noxafil 33

Figure - noxafil 33

Figure - noxafil 34

Figure - noxafil 34

Figure - noxafil 35

Figure - noxafil 35

Figure - noxafil 36

Figure - noxafil 36

Figure - noxafil 37

Figure - noxafil 37

Figure - noxafil 38

Figure - noxafil 38

Figure - noxafil 39

Figure - noxafil 39

Figure - noxafil 40

Figure - noxafil 40

Figure - noxafil 41

Figure - noxafil 41

Figure - noxafil 42

Figure - noxafil 42

Principal Display Panel - 300 mg Carton - noxafil 43

Principal Display Panel - 300 mg Carton - noxafil 43

Noxafil PowderMix is an oral suspension containing 300mg of posaconazole. It is stored at a room temperature of 20 to 25°C and should be administered with the provided notched-tip syringes within an hour of mixing. The recommended dosage and usage instructions can be found in the prescribing information provided. The Multi-Dose Kit contains instructions for use, syringes, mixing liquid, bottle adapter, and 8 packets of Noxafil PowderMix. Additional notched-tip syringes are provided in Package B.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.